Judge Orders Johnson & Johnson Unit to Pay $125 Million in AI Imaging Dispute with ChemImage

In a significant ruling, a New York federal judge determined that Ethicon Inc., a subsidiary of Johnson & Johnson, is liable for approximately $125 million to ChemImage Corp. This decision involves a termination fee of $40 million and intellectual property impairment damages estimated at $85 million. The dispute arose following Ethicon’s unilateral termination of their collaborative agreement aimed at developing artificial intelligence imaging techniques for use during surgery. The implications of this ruling shed light on the legal repercussions companies may face when prematurely ending joint ventures, especially in the realm of cutting-edge technology development. Further details on this legal development are available through the original article.